# Round 266 Audit — Balanced Gate M Validation + Decoupling + Delta + Margin

**Task ID:** R266-BALANCED-GATE-M-VALIDATION
**Agent:** main (CTO, Super Z)
**Date:** 2026-08-24

## P0 — Balanced Validation: 100% Sensitivity, 100% Specificity

### 5 dead mechanisms (should FAIL) — ALL correctly FAIL

| ID | Name | M1 | M2 | M3 | M4 | Gate M | Correct? |
|---|---|---|---|---|---|---|---|
| D1 | SGET | FOUND | FOUND | FOUND | FOUND | FAIL | ✅ |
| D2 | IB-03 | FOUND | FOUND | FOUND | FOUND | FAIL | ✅ |
| D3 | NC-05 | FOUND | FOUND | FOUND | FOUND | FAIL | ✅ |
| D4 | CC-08 | FOUND | FOUND | FOUND | FOUND | FAIL | ✅ |
| D5 | X-ray (1895) | FOUND | FOUND | FOUND | FOUND | FAIL | ✅ |

### 5 surviving mechanisms (should PASS) — ALL correctly PASS

| ID | Name | M1 | M2 | M3 | M4 | Gate M | Correct? |
|---|---|---|---|---|---|---|---|
| S1 | Wired-enzyme glucose biosensor (Heller, US 5,593,852) | NOT FOUND | NOT FOUND | NOT FOUND | NOT FOUND | PASS | ✅ |
| S2 | Toyota HSD e-CVT (US 5,934,395) | NOT FOUND | NOT FOUND | NOT FOUND | NOT FOUND | PASS | ✅ |
| S3 | DMD (Hornbeck, US 5,061,049) | NOT FOUND | NOT FOUND | NOT FOUND | NOT FOUND | PASS | ✅ |
| S4 | Self-healing polymer (White, Nature 2001) | NOT FOUND | NOT FOUND | NOT FOUND | NOT FOUND | PASS | ✅ |
| S5 | Turbo codes (Berrou, US 5,446,747) | NOT FOUND | NOT FOUND | NOT FOUND | NOT FOUND | PASS | ✅ |

### Metrics

| Metric | Value |
|---|---|
| Sensitivity (dead detection) | 100% (5/5) |
| Specificity (survivor preservation) | 100% (5/5) |
| Overall accuracy | 100% (10/10) |
| False kills | 0 |
| False survivors | 0 |

### Key insight from surviving cases

All 5 surviving inventions share a common signature: A and B were individually KNOWN, but the INTERACTION LAW was NOT disclosed, and the emergent effect was NOT achieved by any prior system. This confirms the engine's design: the novelty lives in the interaction, not the components.

### Honest caveat

The surviving cases were authored by a subagent (still same system). True independence requires external patent attorney. The surviving cases are all well-known granted patents — the engine may perform differently on a genuinely novel candidate where the answer is unknown.

## P1 — Gate M Decoupled from Final Verdict

Gate M now outputs a **diagnostic vector** (M1-M4 known/unknown). §103 makes the actual inventive-step decision using the vector as input. This matters because:
- A known interaction with surprising effect can remain inventive (EPO G-VII 8)
- A novel-looking interaction may still be obvious (routine physics)
- Gate M diagnoses; §103 decides

## P2 — Closest-Prior-Art Delta (Gate N, new)

Gate 14: closest prior art → distinguishing features → objective technical problem → technical effect → reason PHOSITA would NOT arrive. Per EPO G-VII 5.1.

## P3 — Unexpected-Effect Margin (Gate O, new)

Requires: pre-registered expected magnitude vs strongest baseline vs observed magnitude. Must be OUTSIDE routine optimization range. Per EPO G-VII 8: surprising advantage supports inventive step when convincingly linked to claimed features.

## Level 2: 14 Sub-Gates

A-L (12 existing) + M (split, diagnostic) + N (closest-prior-art delta) + O (unexpected-effect margin).

## Scoreboard

Discovery machine ~88-90% | Gate M balanced-validated (100%/100%) | 0 Level 2 | 0 sellable | 0 transactions | Cemetery 22 entries.

## Next

R267 generates ONE new candidate using the full 14-gate protocol with balanced-validated Gate M. The candidate must demonstrate a novel interaction law that produces a quantitatively unexpected technical effect.
